Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Deficiency”

276 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 276 results

Not applicableLooking for participantsNCT07255157
What this trial is testing

Peripheral Helper T-cells in Common Variable ImmunoDeficiency

Who this might be right for
Common Variable Immunodeficiency
University Hospital, Bordeaux 60
Large-scale testing (Phase 3)WithdrawnNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc.
Not applicableLooking for participantsNCT06823596
What this trial is testing

The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY

Who this might be right for
Hiv
University of Toronto 26
Early research (Phase 1)Ended earlyNCT00757250
What this trial is testing

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

Who this might be right for
HIV Infections
US Biotest, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Testing effectiveness (Phase 2)Looking for participantsNCT03266640
What this trial is testing

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Who this might be right for
Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Early research (Phase 1)Study completedNCT00083330
What this trial is testing

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

Who this might be right for
HealthyHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)UnknownNCT02231281
What this trial is testing

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

Who this might be right for
Acute HIV Infection
Yongtao Sun, MD, PhD 65
Early research (Phase 1)Study completedNCT00093743
What this trial is testing

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+8 more
Fred Hutchinson Cancer Center 2
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT03212989
What this trial is testing

Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)

Who this might be right for
HIV-1 Infection
University of North Carolina, Chapel Hill 17
Not applicableStudy completedNCT00006298
What this trial is testing

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 125
Not applicableStudy completedNCT00027482
What this trial is testing

Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

Who this might be right for
HealthyHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 2,000
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableNot Yet RecruitingNCT06889142
What this trial is testing

Impact of NMN Supplementation on CD4+ T Cell Recovery in HIV Patients With Immunological Failure

Who this might be right for
Human Immunodeficiency Virus
TriHealth Inc. 7
Not applicableStudy completedNCT00002059
What this trial is testing

Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers

Who this might be right for
HIV Infections
Newport Pharmaceuticals International
Not applicableStudy completedNCT00908544
What this trial is testing

New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients

Who this might be right for
HIV Infections
MUC Research GmbH 47
Not applicableEnded earlyNCT02246491
What this trial is testing

Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia

Who this might be right for
Ataxia-Telangiectasia (A-T)
Johns Hopkins University 6
Testing effectiveness (Phase 2)Study completedNCT00071240
What this trial is testing

Growth Hormone to Increase Immune Function in People With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00001386
What this trial is testing

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Cancer Institute (NCI) 31
Next Page